This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Through T cell engineering, researchers at Virginia Commonwealth University Massey Cancer Center show that it’s possible to arrest tumor growth for a variety of cancers and […]. A new approach to immunotherapy arrests solid tumor growth for a variety of cancers and squashes the spread of cancer to other tissues, in mice.
Announces exclusive licensing partnerships for proprietary regulatory T cell engineering technologies with Seattle Children’s Research Institute, Benaroya Research Institute and MIGAL Galilee Research Institute Credit: GentiBio, Inc. BOSTON, Mass., SEATTLE, Wash., and QIRYAT SHMONA, Israel, August 5, 2020 – GentiBio, Inc.,
Voyage Foods, a California-based startup that has reverse-engineered chocolate, peanut butter and coffee, recently closed a $36 million Series A investment round. She discusses the problematic sourcing and production challenges associated with chocolate and coffee, as well as the millions of Americans that have peanut allergies.
AI’s margin gains simply aren’t as big an incentive for life sciences businesses to embark on multi-year data engineering projects. We’re also insulated from issues like labor shortages that have driven other industries to seek AI efficiency gains. Yet, the opportunity extends beyond simply increasing profitability.
In this type of therapy, T cells, a type of white blood cell, are collected from a patient’s blood and subjected to genetic engineering to produce T cells carrying a synthetic molecule termed chimeric antigen receptor (CAR) […].
A new study has found that a novel T cell genetically engineered by University of Arizona Health Sciences researchers is able to target and attack pathogenic T cells that cause Type 1 diabetes, which could lead to new immunotherapy treatments.
Investments have catalyzed research, clinical trials and revolutionary treatments across many disciplines UC San Francisco is launching a new initiative to propel the development of living therapeutics – a category of treatments broadly defined as human and microbial living cells that are selected, modified, or engineered to treat or cure disease (..)
Research from the Texas A&M College of Engineering could lead to new approaches to treating viruses and cancers Credit: Dr. Wonmuk Hwang, Texas A&M University College of Engineering Research led by Dr. Wonmuk Hwang has led to better understanding on how components of the body’s immune system find intruding or damaged cells, which could (..)
labeling of major food allergens in bulk foods, dietary supplements, protein-free ingredients, and foods produced through genetic engineering); and. labeling of major food allergens in bulk foods, dietary supplements, protein-free ingredients, and foods produced through genetic engineering); and. Other technical labeling matters.
It is sponsored by the US-government funded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health. AZ went on to engineer the antibodies to have a longer half-life in the body with its proprietary technology.
This requires an 11-day programme which involves extracting blood from an HIV patient and separating their T cells, which are then engineered in a lab to make them immune to HIV. In a paper published in Molecular Therapy: Methods & Clinical Development , the team discussed why they choose this type of gene therapy to treat HIV.
Now, researchers at the Pritzker School of Molecular Engineering (PME) at the University of Chicago […]. But just how immune cell receptors work together to sense multiple molecules and make these decisions remained a mystery.
Engineered to instruct the immune system to generate T cells capable of recognizing HIV and triggering an immune response to thwart the establishment of chronic infection, VIR-1388 represents a promising avenue in HIV prevention. In addition, Vir Biotechnology, Inc.
This groundbreaking endeavor has received support from the National Institute of Allergy and Infectious Diseases (NIAID). These T cells are engineered to recognize various HIV proteins in a unique manner compared to previous experimental HIV vaccines.
Researchers at the Pritzker School of Molecular Engineering at the […]. But many cancer immunotherapy treatments can be expensive, have devastating side effects, and only work in a fraction of patients.
The precision fermentation study highlights how genetically engineered microorganisms can inhibit the growth of foodborne pathogens. The study proposes a new system for categorizing genetically engineered products to improve public perception and acceptance.
The IVT mRNAs are structurally similar to natural mRNAs, these synthetic mRNAs can be used to express proteins through genetic engineering. In the last few years, researchers have become interested in using in vitro transcribed (IVT) mRNA as a drug delivery agent.
The phase 1 study that is being run by the National Institute of Allergy and Infectious Diseases tests three dose levels of the vaccine, mRNA-1273, given in two injections a month apart in 120 adults. Moderna showed robust phase 1 results for its COVID-19 vaccine in adults up to 55 last month.
It inked a deal with the National Institute of Allergy and Infectious Diseases (NIAID) to launch a Phase I trial. National Institute of Allergy and Infectious Diseases (NIAID), of bamlanivimab (LY-CoV555) decreased the risk of COVID-19 among residents and staff of long-term care facilities, i.e., nursing homes.
relating to cancer, tuberculosis, human immunodeficiency virus infection and acquired immune deficiency syndrome, or any genetic muscle diseases or disorders) Must not have hypersensitivity or known allergy to any medications Must be able to attend study visits at the research site over approximately 14 weeks (without interference of vacations etc.)
In advance of public vaccination, a quick and accurate COVID-19 antibody test will help determine the presence of neutralizing antibodies, the molecules that aid in protection against the virus. Credit: UAB BIRMINGHAM, Ala.
An Fc-engineered monoclonal antibody targeting the HER2 oncoprotein, MARGENZA offers hope for patients who have received two or more prior anti-HER2 regimens, with at least one being for metastatic disease. When Pigs Fly Allergy-friendly. Importantly, a consistent safety profile was maintained.
Research sets the stage for biotech to generate 1 billion doses in less than a month Credit: Justin Muir By cracking open a cellular membrane, Northwestern University synthetic biologists have discovered a new way to increase production yields of protein-based vaccines by five-fold, significantly broadening access to potentially lifesaving medicines. (..)
Lysyl oxidase plays several important roles in promoting fibrosis in patients with scleroderma and is a potential biomarker of treatment response Credit: Sarah Pack, Medical University of South Carolina A team of researchers at the Medical University of South Carolina (MUSC) has found that the molecule lysyl oxidase (LOX) plays a number of important (..)
Susan Landau’s ‘People Count’ Credit: The MIT PRESS, 2021. How do you stop a pandemic before a vaccine arrives? Contact tracing is key, the first step in a process that has proven effective: trace, test, and isolate.
Department of Health and Human Services (HHS), and the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH) at HHS. NVX-CoV2373 is a protein-based vaccine candidate engineered from the genetic sequence of the first strain of SARS-CoV-2, the virus that causes COVID-19 disease.
Working with experts using an AI-powered platform that engineers food proteins, Bayer is supporting science to help the hundreds of millions of people around the world who suffer from food allergies or sensitivities, including gluten. Improving diets through increased quality and access.
Research highlights the critical role of the immune system in the aging process Researchers from the Buck Institute and Stanford University have created an inflammatory clock of aging (iAge) which measures inflammatory load and predicts multi-morbidity, frailty, immune health, cardiovascular aging and is also associated with exceptional longevity in (..)
In a limited number of cases when a full virus does not contain any known gain of function mutations, such virus may be engineered to enable the assessment of antiviral activity in cells. Most of this work is conducted using computer simulations or mutations of the main protease–a non-infectious part of the virus.
In rankings recently released by the National Science Foundation, Pitt ranked fifth among all American universities in total federal science and engineering research and development support.
Viruses make copies of themselves during an infection, and new research sheds light on one of the coronavirus molecules that is important for this process, providing a potential drug target that could work for Covid-19 and other coronavirus outbreaks too. Credit: Image courtesy of Keith Mickolajczyk.
A new study concludes that opening clinics dedicated specifically to treating influenza can limit the number of people infected and help to “flatten the curve,” or reduce the peak prevalence rate. “Dedicated clinics […].
Credit: Earlham Institute Respiratory viruses such as SARS-CoV-2 (causing COVID-19) can often catalyse an overactive immune response that leads to a life-threatening cycle, known as a cytokine storm.
Garrido, CNIO The sophisticated human immune system has evolved to become an effective protection system against a great number of diseases, cancer being one of them. The immune system recognises and destroys cancer cells using a monitoring process called immunological surveillance.
Katalin Karikó receives the 2022 Vilcek Prize for Excellence in Biotechnology for her scientific contributions that led to the development of mRNA vaccines for COVID-19 NEW YORK, June 8, 2021–Dr.
Newly-published “contact lens technologies of the future” paper reviews innovative uses for disease detection and therapy, drug delivery, vision enhancement and mor Credit: Centre for Ocular Research & Education (CORE) WATERLOO, Ontario, March 29, 2021–A newly-published paper represents one of the most comprehensive reviews of (..)
Research from the California Institute of Technology shows exactly how antibodies stick to and block the Zika virus, which will inform vaccine development Credit: Image courtesy of Shannon Esswein.
Credit: Sanford Burnham Prebys LA JOLLA, CALIF. – June 29, 2021 – Carl F. Ware, Ph.D., director of the Inflammatory Diseases Center at Sanford Burhnam Prebys, has received the 2021 International Cytokine & Interferon Society Honorary Lifetime Membership Award.
We organize all of the trending information in your field so you don't have to. Join 21,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content